Put New Aimovig for Migraine Prophylaxis Into Perspective
August 2018
You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraine in adults.
It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.
Expect other "CGRP antagonists" to be approved within a few months.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote